![](/img/cover-not-exists.png)
PCN79 COST EFFECTIVENESS OF OSIMERTINIB VERSUS CHEMOTHERAPY IN SECOND LINE TREATMENT OF NON SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR AND 790M MUTATION IN CHILEAN HEALTH SYSTEM
Rojas, R., Balmaceda, C.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.203
Date:
May, 2019
File:
PDF, 381 KB
english, 2019